STUDIES ON THE SUBSTRATE-SPECIFICITY OF THE PROTEINASE OF EQUINE INFECTIOUS-ANEMIA VIRUS USING OLIGOPEPTIDE SUBSTRATES

被引:36
作者
TOZSER, J
FRIEDMAN, D
WEBER, IT
BLAHA, I
OROSZLAN, S
机构
[1] NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, MOLEC VIROL & CARCINOGENESIS LAB, FREDERICK, MD 21702 USA
[2] THOMAS JEFFERSON UNIV, JEFFERSON CANC INST, DEPT PHARMACOL, PHILADELPHIA, PA 19107 USA
[3] DEBRECEN UNIV MED, DEPT BIOCHEM, H-4012 DEBRECEN, HUNGARY
[4] CZECHOSLOVAK ACAD SCI, INST ORGAN CHEM & BIOCHEM, CS-16610 PRAGUE 6, CZECHOSLOVAKIA
关键词
D O I
10.1021/bi00064a018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The proteinase of the equine infectious anemia virus (EIAV), a lentivirus closely related to human immunodeficiency virus (HIV), was purified from concentrated virus. The specificity of the enzyme was characterized using oligopeptides representing naturally occurring cleavage sites in the Gag and Gag-Pol polyproteins. The length of the substrate binding pocket was found to be 1-2 residues longer than that of HIV proteinases. Although the EIAV and HIV proteinases cleaved most of the peptides at the same bond, some were hydrolyzed by only the EIAV enzyme. Oligopeptides representing cleavage sites in the nucleocapsid protein were also found to be substrates of the EIAV proteinase. However, these peptides were not hydrolyzed by the HIV proteinases. While peptides representing the corresponding sequences in the first cysteine arrays of the nucleocapsid proteins of HIV-1 and HIV-2 were substrates of the proteinases, peptides representing the homologous sequences in the second Cys arrays were resistant against the proteolytic attack. A three-dimensional model of the EIAV proteinase built on the basis of homology with HIV-1 proteinase was used to interpret the differences. In addition to the oligopeptides representing cleavage sites in the Gag and Gag-Pol polyproteins, the EIAV proteinase was also able to cleave an oligopeptide mimicking a cleavage site in the transmembrane protein. Our results suggest that the specificity of lentiviral proteinases share common characteristics, although substantial differences may exist in hydrolysis of some peptides.
引用
收藏
页码:3347 / 3353
页数:7
相关论文
共 58 条
[1]   HIGH-LEVEL EXPRESSION OF ENZYMATICALLY ACTIVE BOVINE LEUKEMIA-VIRUS PROTEINASE IN ESCHERICHIA-COLI [J].
ANDREANSKY, M ;
HRUSKOVAHEIDINGSFELDOVA, O ;
SEDLACEK, J ;
KONVALINKA, J ;
BLAHA, I ;
JECMEN, P ;
HOREJSI, M ;
STROP, P ;
FABRY, M .
FEBS LETTERS, 1991, 287 (1-2) :129-132
[2]  
BLAHA I, 1991, INT J PEPT PROT RES, V38, P453
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   EQUINE INFECTIOUS-ANEMIA VIRUS - EVIDENCE FAVORING CLASSIFICATION AS A RETRA-VIRUS [J].
CHARMAN, HP ;
BLADEN, S ;
GILDEN, RV ;
COGGINS, L .
JOURNAL OF VIROLOGY, 1976, 19 (03) :1073-1079
[5]   NUCLEOTIDE-SEQUENCE EVIDENCE FOR RELATIONSHIP OF AIDS RETROVIRUS TO LENTIVIRUSES [J].
CHIU, IM ;
YANIV, A ;
DAHLBERG, JE ;
GAZIT, A ;
SKUNTZ, SF ;
TRONICK, SR ;
AARONSON, SA .
NATURE, 1985, 317 (6035) :366-368
[6]   GENETIC-LOCUS, PRIMARY STRUCTURE, AND CHEMICAL SYNTHESIS OF HUMAN IMMUNODEFICIENCY VIRUS PROTEASE [J].
COPELAND, TD ;
OROSZLAN, S .
GENE ANALYSIS TECHNIQUES, 1988, 5 (06) :109-115
[7]   SUBSTITUTION OF PROLINE WITH PIPECOLIC ACID AT THE SCISSILE BOND CONVERTS A PEPTIDE SUBSTRATE OF HIV PROTEINASE INTO A SELECTIVE INHIBITOR [J].
COPELAND, TD ;
WONDRAK, EM ;
TOZSER, J ;
ROBERTS, MM ;
OROSZLAN, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 169 (01) :310-314
[8]   HIV-1 PROTEASE SPECIFICITY OF PEPTIDE CLEAVAGE IS SUFFICIENT FOR PROCESSING OF GAG AND POL POLYPROTEINS [J].
DARKE, PL ;
NUTT, RF ;
BRADY, SF ;
GARSKY, VM ;
CICCARONE, TM ;
LEU, CT ;
LUMMA, PK ;
FREIDINGER, RM ;
VEBER, DF ;
SIGAL, IS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 156 (01) :297-303
[9]   PURIFICATION AND PARTIAL CHARACTERIZATION OF EQUINE INFECTIOUS-ANEMIA VIRUS REVERSE-TRANSCRIPTASE [J].
DEVICO, A ;
MONTELARO, RC ;
GALLO, RC ;
SARNGADHARAN, MG .
VIROLOGY, 1991, 185 (01) :387-394
[10]   PURIFICATION AND PARTIAL CHARACTERIZATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 REVERSE-TRANSCRIPTASE [J].
DEVICO, AL ;
COPELAND, TD ;
VERONESE, FD ;
OROSZLAN, S ;
GALLO, RC ;
SARNGADHARAN, MG .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (01) :51-60